Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neurocrine Biosciences
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary diagnosis of recurrent MDD or persistent MDD.
Participants currently receiving pharmacological treatment for depression must have been taking current antidepressant medication(s) for ≥8 weeks prior to screening and must be willing and able to continue with current antidepressant medication(s).
Participants must be willing and able to comply with all study procedures and restrictions.
You may not be if
Participants will be excluded from the study if they meet any of the following criteria:
Participant is pregnant or breastfeeding or plan to become pregnant during the study.
Participant has an unstable medical condition or unstable chronic disease.
Participant has a history of neurological abnormalities.
Participant has a current or prior psychiatric disorder diagnosis that was the primary focus of treatment other than MDD.
Participant's depressive symptoms have previously demonstrated nonresponse to an adequate course of treatment with electroconvulsive therapy.
Participant has an alcohol or substance use disorder.
